Team:Paris/Notebook/Protocols
From 2008.igem.org
(→Quantification by Electrophoresis) |
(→Promoter Characterization Plan) |
||
Line 257: | Line 257: | ||
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhDC |
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFliA |
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFliL |
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlgA |
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlgB |
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhB |
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
Line 280: | Line 280: | ||
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |GFP E0240 |
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |OmpR* |
- | | | + | |no |
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |EnvZ* |
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |FliA |
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |FlhDC |
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
|colspan="4"|<center>'''Plasmids'''</center> | |colspan="4"|<center>'''Plasmids'''</center> | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pSB3K3 (ORI p15A) |
+ | |yes | ||
+ | |- style="text-align: center;" | ||
+ | |pSB4T5 (ORI pSC101) | ||
|yes | |yes | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
Line 303: | Line 306: | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
|B0032 | |B0032 | ||
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
|colspan="4"|<center>'''Terminators'''</center> | |colspan="4"|<center>'''Terminators'''</center> | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
|B0010 | |B0010 | ||
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
|B0012 | |B0012 | ||
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
|colspan="4"|<center>'''Bacterial Strains'''</center> | |colspan="4"|<center>'''Bacterial Strains'''</center> | ||
Line 319: | Line 322: | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
|FliA -/ FlhDC - | |FliA -/ FlhDC - | ||
- | | | + | |yes |
|- style="text-align: center;" | |- style="text-align: center;" | ||
|FlgM - | |FlgM - | ||
- | | | + | |yes |
|} | |} | ||
Line 351: | Line 354: | ||
|yes | |yes | ||
| | | | ||
- | | | + | | |
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
Line 360: | Line 363: | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | | |
- | | | + | | |
- | | | + | |GFP E0240 |
|yes | |yes | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhDC |
- | | | + | |yes |
- | | | + | |OmpR* |
- | | | + | |no |
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhDC |
- | | | + | |yes |
- | | | + | |EnvZ* |
- | | | + | |yes |
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhDC |
- | | | + | |yes |
- | | | + | |FliA |
- | | | + | |yes |
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFliA |
- | | | + | |yes |
- | | | + | |FlhDC |
|yes | |yes | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFliA |
- | | | + | |yes |
- | | | + | |FliA |
- | | | + | |yes |
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFliL |
- | | | + | |yes |
- | | | + | |FlhDC |
|yes | |yes | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFliL |
- | | | + | |yes |
- | | | + | |FliA |
- | | | + | |yes |
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlgA |
|yes | |yes | ||
- | | | + | |FlhDC |
|yes | |yes | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlgA |
+ | |yes | ||
+ | |FliA | ||
|yes | |yes | ||
- | |||
- | |||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
|PflgB | |PflgB | ||
|yes | |yes | ||
- | | | + | |FlhDC |
|yes | |yes | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlgB |
+ | |yes | ||
+ | |FliA | ||
|yes | |yes | ||
- | |||
- | |||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhB |
|yes | |yes | ||
- | | | + | |FlhDC |
|yes | |yes | ||
| | | | ||
|- style="text-align: center;" | |- style="text-align: center;" | ||
- | | | + | |pFlhB |
+ | |yes | ||
+ | |FliA | ||
|yes | |yes | ||
- | |||
- | |||
| | | | ||
|} | |} |
Revision as of 14:18, 20 October 2008
Culture of Stable strain with biobricks 2008
Glycerol Stocks
Minipreps (QIAGEN kit)
ElectrophoresisAn electrophoresis can be done to check if there is Product of Miniprep
Concentration of the MiniprepBy biophotometry
Check if the ratio 260/280 is over 1,6 Think about the dilution ! Digestion
Migration after digestion
Separate each band by an empty one ! Extraction
Amplification of promoters(to amplify the sequence in order to have enough amount of DNA to carry out the following of our experiments)
For each samples
1 µl dNTP
LID : 105°C Purification (PROMEGA or QIAcube or QIAquick kit)Gel Slice and PCR Product PreparationDissolving the Gel Slice
Processing PCR reactionsFor products above 40 pb
Binding of DNA
Washing
Elution
Quantification by Electrophoresis
Ligation
TransformationUse chemically lab-made competent cells or from a kit (DH5α, TOP10, Mach1)
LB and LBA
Minimum Medium
- B1 Vitamin 0.1%
Filter the medium with a cell-culture unit of filtration. If needed add the appropriate antibiotic to a final concentration of 1X 1000X stock antibiotic
PCR ScreeningUse of 8 clones of Ligation transformants for screening PCR
After, add
Store the tubes on ice waiting for PCR attains 95°C then put the tubes in the machine
LID 105°C Electrophoresis Purification of PCR
Sequencing[http://institut.cochin.inserm.fr/rubric_recherche/Plates-Formes/sequencage_genomique/I18NFolder.2005-02-10.4781618697/page2/fr Sequencing COCHIN]
Promoter Characterization PlanFor theoretical consideration, see estimation of parameters
The same colour coded steps can be perfomed at the same time if elements needed are available The order for treating the colours should of course be:
This table contains the promoters we need to characterize, the transcription factors whose effect on the promoter we want to test, and the plasmid we want to obtain in order to carry out each characterization
Protocol to make competent bacteria1. Use non competent bacteria (ex: MG1655) stocked in 1.5 mL LB (20% Glycerol): put a sterile tip in the 1.5 mL stock tube and then place it in a 50 mL Falcon with 5 ml LB medium. Over Night culture at 37°C / 300 rpm 2. 1/100 dilution in LB medium QSP 50 mL in an erlenmeyer of 250 mL 3. Culture at 37°C / 300 rpm untill OD600 reach 0.6 4. Fast cooling at +4°C by gently shaking the erlen in ice Before: prepare CaCl2 0.1M.
5. Use pre-cooled centrifuge at +4°C. Centrifuge 50 mL of the culture in 50 mL falcon: +4°C / 5 min / 5000 rpm 6. Discard supernatant by inverting the tube, and resuspend the pellet with 1 mL of cold CaCl2 and mix gently the suspension by up and down 7. Add cold CaCl2 QSP 20 mL and incubate 30 min / +4°C 8. Centrifuge the suspension : +4°C / 5 min / 5000 rpm 9. Discard supernatant by inverting the tube, and resuspend the pellet with 1 mL of cold CaCl2 and mix gently the suspension by up and down 10. Transform or freeze the competent cells. Freeze the competent cells in 50 µL aliquots in the 0.1M CaCl2 medium with 15% glycerol. 11. After transformation, prepare a Glycerol Stock or/and use the transformed bacteria to study the doubling time of the bacteria population Study of the doubling time of the bacteria population
|